Yuki Otani
7PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants.Yuki Otani, Christopher D Payne, Edward V Loftus
|Sep 03, 2025
Pharmacokinetic Bridging Between an Autoinjector and a Prefilled Syringe Following Subcutaneous Administration of Mirikizumab in Healthy Participants.Xin Zhang, Yuki Otani, Christopher D Payne
|Aug 14, 2025
Mirikizumab Pharmacokinetics and Exposure-Response in Patients With Moderately-To-Severely Active Crohn's Disease: Results From Two Randomized Studies.Laiyi Chua, Yuki Otani, Zhantao Lin
|Mar 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials.Yuki Otani, Brian G Feagan, Geert R D'Haens
|Dec 18, 2024
Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis.Yuki Otani, Laiyi Chua, Wendy J Komocsar
|Sep 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone.Yuki Otani, Yunqi Zhao, Guanyu Wang
Pageof 2
Frequent Collaborators
4 joint publications
Xin Zhang
3 joint publications
Christopher D Payne
3 joint publications
Laiyi Chua
2 joint publications
Nathan J Morris
2 joint publications
Geert R D'Haens
1 joint publications
Yunqi Zhao
1 joint publications
Guanyu Wang
1 joint publications
Majid Vakilynejad
1 joint publications
Dean Bottino
1 joint publications
Yusuke Tanigawara
